{"schema_version":"secwatch.filing_event.v1","accession":"0001093557-25-000050","form_type":"8-K","ticker":"DXCM","cik":"0001093557","company_name":"DEXCOM INC","filed_at":"2025-03-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:02.910025+00:00","generated_at":"2026-05-25T00:47:33.392938+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"DexCom appoints Renée Galá, Jazz Pharmaceuticals COO, to board","bullets":["Renée Galá appointed to DexCom board effective March 6, 2025; term expires at the 2025 annual meeting.","Galá currently serves as President and COO of Jazz Pharmaceuticals, with prior CFO roles at Jazz and Theravance Biopharma.","Received an initial RSU grant with a fair value of $500,000, vesting annually over three years.","Board determined Galá qualifies as an independent director under Nasdaq rules.","Galá also eligible for a pro-rated annual director RSU grant of $56,986 around the 2025 annual meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001093557-25-000050","json":"https://secwatch.observer/filing/0001093557-25-000050.json","markdown":"https://secwatch.observer/filing/0001093557-25-000050.md","text":"https://secwatch.observer/filing/0001093557-25-000050.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1093557/000109355725000050/0001093557-25-000050-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1093557/000109355725000050/dxcm-20250306.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-25T00:47:33.392938+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"70b73f6ab9","claim":"Renée Galá was appointed as director at DEXCOM INC.","evidence_excerpt":"On March 6, 2025, the Board of Directors (the “Board”) of DexCom, Inc. (“Dexcom”) increased the size of the Board to eleven directors and appointed Renée Galá as a director effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1093557/000109355725000050/0001093557-25-000050-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"director"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}